Do you have groundbreaking research with commercial potential? Learn what commercialization topics are important and how to transform your research into a compelling business plan and investor-ready pitch deck with TIDO and Curie.Bio on November 19 in the Karp First Floor Boardroom.
Lunch will be served on a first-come, first-served basis. Please RSVP here.
About Curie.Bio
Curie.Bio is a venture capital firm that helps founders discover and develop important new medicines by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch.
Guest Speaker:
George Voren | Vice President, Founder Strategy and Operations
George Voren sits at the intersection of science, business, and medicine. He is currently at Curie.Bio, where he focuses on global sourcing of new therapeutic companies. He works closely with scientific teams to shape company concepts, design research plans, and guide startups from initial proposal to Series A funding. His role spans sourcing strategy and operations, and founder engagement across a global biotech network. Previously, George was part of the team at Flagship Pioneering, building early-stage biotech ventures such as Vesalius Therapeutics, and worked at Relay Therapeutics, where he contributed to the launch of multiple drug discovery programs in genetic disease. George began his scientific career at The Scripps Research Institute, earning a PhD in Neuropharmacology and contributing to the discovery of the first selective Orexin 1 Receptor Antagonist, which was licensed by AstraZeneca and brought to clinical trials for addiction.
Event Details:
Date: Wednesday, November 19, 2025
Time: 12-1 PM
Location: Karp First Floor Boardroom
RSVP: Click here.
How does a scientific breakthrough become a product that reaches patients? Hear from Boston Children’s Hospital’s Dr. Stuart Orkin and Vertex’s Dr. David Altshuler about the discoveries and developments that led to the first cure for Sickle Cell Disease–Casgevy, a CRISPR/Cas9 gene therapy.
Lunch will be provided on a first-come, first-served basis.
Guest Speakers:
- Stuart Orkin, MD | Professor of Pediatrics- Harvard Medical School, Boston Children’s Hospital
- David Altshuler, MD, PhD |Executive Vice President and Chief Scientific Officer- Vertex Pharmaceuticals
Moderator:
- Irene Abrams | Senior Vice President for Research Innovation- Boston Children’s Hospital
Event Details:
Date: Tuesday, December 2, 2025
Time: 11:30 AM-1 PM
Location: Folkman Auditorium
RSVP: Click here.